remaining life span, but any risks are immediate.”
An additional thought: Topical imiquimod can be helpful in the management of superficial and nodular basal cell carcinomas.(2) The marked inflammatory response is often difficult for patients to tolerate, but less frequent applications may allow for palliation and slowing of tumor progression.
You thoughts will be appreciated.
2. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.